Purchase Order 75F40121P00451
- Not listed
- The U.S. Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp for a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer on September 29, 2021. The contract, which was completed by September 28, 2022, fulfills the FDA's Center for Drug Evaluation and Research requirement for high-resolution analytical equipment to characterize pharmaceutical ingredients, drug products, and excipients for stability and quality assessment in both liquid and...
- The Food and Drug Administration awarded Bruker Scientific LLC a firm fixed-price purchase order valued at $106,500 for a BIOTYPER Complete Care Service Agreement. The contract, which was awarded on January 15, 2021, with an ultimate completion date of January 14, 2026, will be performed at Bruker Scientific LLC's facility in Billerica, Massachusetts. This award was made through full and open competition with no small business set-aside designation. The service agreement supports the FDA's...
- The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price purchase order contract to Bruker Optics Inc., a manufacturer of scientific instruments and solutions, for a MATRIX-F FT-NEAR INFRARED (NIR) PROCESS SPECTROMETER. The contract has a potential value of $113,293.60 and a completion date of November 9, 2018. The contract does not have a set-aside designation. Bruker Optics Inc. has previously provided Fourier transform infrared spectrometers, Raman...
- The Food and Drug Administration awarded a $117,198.84 firm fixed-price purchase order to Bruker Scientific LLC for preventive maintenance and repair services on a Bruker Autoflex Speed Time-of-Flight mass spectrometer (serial number 8264420.00551) located at the FDA's Silver Spring, Maryland facility. The solicitation was posted on December 10, 2020, with award finalized on December 30, 2020, establishing an ultimate completion date of December 30, 2024. This contract required no set-aside...
- The U.S. Food and Drug Administration (FDA) awarded a $145,277.00 firm-fixed-price purchase order contract to Bruker Scientific LLC for preventive maintenance and repair services for a Bruker 7T scimaX mass spectrometer system located at the FDA's National Center for Toxicological Research in Jefferson, Arkansas. The contract has a base period of performance from September 20, 2024, to September 19, 2025, with one option year to September 19, 2026. This award was not set aside for any specific...
- Bruker Optics Inc., a subsidiary of Bruker Corporation, was awarded a firm fixed-price purchase order valued at $97,124 by a civilian federal agency (Southeast Area) on July 20, 2018, for a Fourier transform near-infrared (FT-NIR) spectrometer, model MPA II with DataSnap software. The contract specifies performance in Houma, Louisiana, with an ultimate completion date of September 30, 2018. This procurement was not designated as a set-aside contract, indicating open competition. Bruker Optics...
- The Department of Commerce National Institute of Standards and Technology awarded a $111,802.17 firm-fixed-price purchase order to Bruker Scientific LLC, a division of Bruker Corporation, for the procurement of a variable temperature diffuse reflectance infrared Fourier transform spectrometer. The contract has a completion date of December 7, 2023. Bruker Scientific, a manufacturer of scientific instruments, has previously delivered specialized equipment like mass spectrometry systems and...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Bruker Scientific LLC for preventive maintenance services on a Bruker MALDI Biotyper Sirius GP System 2, with a contract ceiling value of $75,900. The contract, issued on February 23, 2024, represents a one-year maintenance option period for analytical equipment located at the FDA's facility in Silver Spring, Maryland, with an ultimate completion date of February 22, 2027. No small business set-aside was applied to...
- Bruker Scientific LLC, a Billerica, Massachusetts-based manufacturer of advanced scientific instruments, received a $1.14M firm fixed-price delivery order from the Office of Administrative Services Procurement Management Branch for equipment and supplies supporting three laboratories. The contract was awarded on May 25, 2021, with an ultimate completion date of October 5, 2021, and was performed at the awardee's Billerica facility. No set-aside designation was used in this competitive award,...
- The Food and Drug Administration awarded a $120,290.40 firm fixed price purchase order to Bruker Biospin Corp for a Cryoprobe/Cryoplatform System Service Agreement. The contract, which was not set aside for small businesses, was awarded on July 11, 2023, with an ultimate completion date of September 24, 2026. Work will be performed at Bruker Biospin Corp's facility in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, specializes in the design, manufacture, and...
The Food and Drug Administration awarded Bruker Scientific LLC a firm fixed price purchase order valued at $40,027.50 for a Process Analytical Technology Probe for Near-Infrared (PATPNIR) spectroscopy. The contract was awarded on August 18, 2021, following a competitive solicitation posted on July 16, 2021, with a completion date of November 16, 2021. The place of performance is located in Billerica, Massachusetts, where Bruker Scientific LLC maintains its headquarters. No set-aside designation was applied to this contract, indicating full and open competition. This procurement aligns with FDA's mission to ensure the safety and effectiveness of pharmaceutical and food products through advanced analytical capabilities. Bruker Scientific LLC, a subsidiary of Bruker Corporation, is a prominent manufacturer of advanced scientific instruments and analytical solutions with extensive experience supporting federal research and regulatory agencies. The company specializes in sophisticated analytical equipment including spectroscopy systems, mass spectrometers, and detection technologies. The PATPNIR acquisition supports FDA's analytical laboratory operations, likely at the National Center for Toxicological Research or another FDA facility requiring near-infrared spectroscopic capabilities for quality control and product analysis. Bruker Scientific LLC has demonstrated considerable federal contracting experience, holding significant indefinite delivery vehicles with the Department of Defense, Department of Veterans Affairs, and National Institutes of Health for specialized scientific instrumentation and maintenance services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Brand Name or Equal - Bruker Process Analytical Technology Probe for NIR | 75F40121Q00103 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 7/16/21, 6:38 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 8/17/21 |